Icu Medical (ICUI) Shares Outstanding (Weighted Average) (2009 - 2026)

Icu Medical has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $24.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 0.92% year-over-year to $24.8 million; the trailing twelve-month figure through Mar 2026 stood at $24.8 million (up 0.92% YoY), and the FY2025 full-year result was $24.6 million, up 1.03% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $24.8 million, up from $24.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $24.8 million in Q1 2026, with the low at $23.6 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $24.2 million across 5 years, with a median of $24.2 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) rose 12.72% — and 2023, when it gained 0.62%.
• Icu Medical's Shares Outstanding (Weighted Average) stood at $23.9 million in 2022, then grew by 0.93% to $24.1 million in 2023, then climbed by 1.23% to $24.4 million in 2024, then increased by 1.03% to $24.6 million in 2025, then climbed by 0.5% to $24.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $24.8 million (Q1 2026), $24.6 million (Q4 2025), and $24.6 million (Q3 2025), per Business Quant data.